1Amending the act of September 9, 1965 (P.L.497, No.251),
2entitled, as amended, "An act requiring physicians, hospitals
3and other institutions to administer or cause to be
4administered tests for genetic diseases upon infants in
5certain cases," further providing for newborn child screening
6and follow-up program.

7The General Assembly of the Commonwealth of Pennsylvania
8hereby enacts as follows:

9Section 1. Section 3(a)(1) of the act of September 9, 1965
10(P.L.497, No.251), known as the Newborn Child Testing Act,
11amended July 4, 2008 (P.L.288, No.36), is amended to read:

12Section 3. Newborn Child Screening and Follow-up Program.--
13(a) In order to assist health care providers to determine
14whether treatment or other services are necessary to avert
15mental retardation, permanent disabilities or death, the
16department, with the approval of the Newborn Screening and
17Follow-up Technical Advisory Committee, shall establish a
18program providing for:

19(1) The screening tests of newborn children for the

1following diseases:

2(i) Phenylketonuria (PKU).

3(ii) Maple syrup urine disease (MSUD).

4(iii) Sickle-cell disease (hemoglobinopathies).

5(iv) Galactosemia.

6(v) Congenital adrenal hyperplasia (CAH).

7(vi) Primary congenital hypothyroidism.

8(vii) Certain Lysosomal storage disorders (LSDs), including:

9(A) Globoid Cell Leukodystrophy (Krabbe).

10(B) Fabry.

11(C) Pompe.

12(D) Niemann-Pick.

13(E) Gaucher.

14(F) Hurler Syndrome (MPS I).

15* * *

16Section 2. This act shall take effect in 60 days.